August 3, 2021
1 min read

Pfizer, Moderna raise Covid-19 vaccine prices in EU


The supply contracts are being renewed as Europe is anxious to secure supplies for potential booster shots in the face of the spread of the highly infectious Delta variant…reports Asian Lite News.

US drug makers Pfizer and Moderna have increased the prices of their mRNA-based vaccines against Covid-19 for the European market, the media reported.

According to the new contracts, a Pfizer shot will now cost 19.50 euros against 15.50 euros previously, while a Moderna jab has been priced at 21.49 euros a dose, from about 19 euros in the first procurement deal, The Financial Times reported.

The supply contracts are being renewed as Europe is anxious to secure supplies for potential booster shots in the face of the spread of the highly infectious Delta variant.

Further, the terms of the deals, struck this year for a total of up to 2.1 billion shots until 2023, were renegotiated after phase 3 trial data showed the two companies’ mRNA vaccines had higher efficacy rates than shots developed by Oxford/AstraZeneca and Johnson & Johnson, the report said.

The companies had capitalised on their market power and deployed the “usual pharma rhetoric… Vaccines work so they increased the ‘value’,” the report quoted an official close to the negotiations official.

Riding on the success of its Covid vaccine, Pfizer, last week, raised its annual vaccine revenue to $33.5 billion in 2021, up from the previously projected $26 billion.

Prices for higher-income countries were “comparable”, with middle-income countries charged about half and lower-income countries paying cost, Chief executive Albert Bourla was quoted as saying.

Moderna is expected to announce the second quarter financial results this week. According to forecasts compiled by Airfinity, a life sciences consultancy, the sales of Pfizer’s Covid jab will hit 47.1 billion euros with Moderna’s reaching 25.2 billion euros, the FT reported.

On the other hand, sales of Oxford/AstraZeneca’s Covid jab — the largest vaccine supplied to low-income countries — is expected to rise to 12.6 billion euros in 2022, it added.

ALSO READ-‘Pfizer, AZ vax antibodies may drop 50% in 3 months’

READ MORE-Pfizer recommends 3rd Covid shot for Delta variant

Previous Story

Scores of thermal power plants not complying with emission norms

Next Story

EU will not recognise Taliban if they gain power by force

Latest from -Top News

Pakistan may face stricter IMF terms

The International Monetary Fund (IMF) will undertake its next funding review for Pakistan in the second half of 2025, with 11 new conditions now attached to the continuation of its Extended Fund

Indian diaspora in Japan backs Operation Sindoor

Members of the Indian diaspora in Japan have strongly endorsed Operation Sindoor, India’s targeted military response to the April 22 terror attack in Pahalgam, Kashmir, praising Prime Minister Narendra Modi’s leadership and

What Sri Lanka Can Learn from Pahalgam

If Sri Lanka’s support for India in combating terrorism is genuine, how can Pakistan—widely accused of using terrorism as a tool against India—be treated as an equal partner….writes A. Jathindra While references
Go toTop

Don't Miss

Biden admin urged to support Covid hit India

US is working closely with its partners in the Indian

SOPs issued for vaccination of people going abroad

The ministry said that it is advised that vaccination may